Skip to main content
. 2020 Oct 14;10:17300. doi: 10.1038/s41598-020-74179-6

Figure 3.

Figure 3

Fibrosis can be modulated by currently-used therapeutic drugs. Pre-stimulated (7 days) cells received an anti-fibrotic compound together with either TGF-β or PDGF. Both the collagen levels over time (left column) and the AUC (right column) are depicted. (a) Type I collagen formation in response to TGF-β and iALK5 treatment form day 7. (b) Type I collagen formation in response to TGF-β and nintedanib treatment form day 7. (c) Type VI collagen formation in response to PDGF and nintedanib treatment form day 7. Four technical replicates were used to assess protein levels over time. Tecknical replicates are 4 and data are shown as mean ± SD. Data were analyzed by two-way ANOVA with Dunnett’s multiple comparisons test54 and AUC52. *P < 0.05, **P < 0.01, ***P < 0.001.